Recovery Following Desflurane Versus Sevoflurane Anesthesia for Outpatient Urologic Surgery in Elderly Females

AUTHORS

Michael S. Green 1 , * , Parmis Green 1 , Lee Neubert 1 , Kirtanaa Voralu 1 , Poovendran Saththasivam 1 , George Mychaskiw 1

1 Hahnemann University Hospital, Drexel University College of Medicine, Philadelphia, USA

How to Cite: Green M S, Green P, Neubert L, Voralu K, Saththasivam P, et al. Recovery Following Desflurane Versus Sevoflurane Anesthesia for Outpatient Urologic Surgery in Elderly Females, Anesth Pain Med. 2015 ; 5(1):e22271. doi: 10.5812/aapm.22271.

ARTICLE INFORMATION

Anesthesiology and Pain Medicine: 5 (1); e22271
Published Online: February 1, 2015
Article Type: Research Article
Received: July 23, 2014
Revised: September 20, 2014
Accepted: October 13, 2014
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: An unresolved question is the time required for the ability to return to complex tasks following anesthesia.

Objectives: This study aims to characterize the severity and duration of cognitive impairment following sevoflurane or desfluane anesthesia after brief surgery using tests of cognitive ability to objectively testing performance.

Patients and Methods: This study is a double blinded randomized controlled trial. Patients were randomized to receive either a desflurane or sevoflurane-based anesthetic. On the morning of the surgery the subjects performed baseline cognitive task tests (Mini Mental Status exam, Trail Making Test Part A and B, Digit Symbol Coding, Hopkins Verbal Learning Test, Stroop Color and Word Test to determine baseline cognitive function. Cognitive testing was repeated 30 minutes and 1 hour after surgery whereas Modified Telephone Interview for Cognitive Status (TICS-M) and Memory Aging Telephone Screen (MATS) was used on the following day of surgery.

Results: Trail Making Test Part B cognitive test showed statistically significant in comparison for pre and post exposure of anesthetics. This difference was seen in the desflurane group. Other cognitive tests did not show differences on exposure to the anesthetic gases.

Conclusions: This study questioned the difference between volatile anesthetic agent’s effects on patients completing a battery of neurocognitive tests attempting to answer if one agent has a more profound effect. Our study shows no statistically significant cognitive decline except for those in the Trail Making Part B in the Desflurane group. This conclusion is limited by the inherent limitations of the study, but does reinforce that the systemic inflammatory response from the surgery contributes cognitive impairment.

Keywords

Delirium Care Postoperative Complications Anesthesia

Copyright © 2015, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

Numerous studies demonstrate patients have improved immediate recovery characteristics following desflurane anesthesia compared to other volatile agents, including sevoflurane. There is limited evidence in the literature to suggest that patients undergoing sevoflurane, compared to desflurane anesthesia, may suffer from limitation in function and cognitive ability for an undetermined period of time following surgery (1-3). These differences are not explained pharmacokinetically and may be a result of a direct neurotoxic effect of sevoflurane. An unresolved question is the time required for the ability to return to complex tasks following anesthesia and if any difference exists depending on volatile anesthetic agent used. Commonly, patients are advised not to drive or make important decisions for 24 hours following anesthesia, but this is not well-studied and proscribed on an empiric, rather than scientific, basis with very limited data available (4). This study aims to better define recovery characteristics and characterize the severity and duration of cognitive impairment following sevoflurane or desfluane anesthesia after brief outpatient urologic surgery in elderly females using tests of cognitive ability to objectively testing performance.

2. Objectives

The primary endpoint was time to opening of eyes following discontinuation of volatile anesthetic, i.e. vaporizer shut-off. Secondary endpoints include performance on cognitive tests, time to fitness for discharge from PACU and return to full activity of daily livings (ADL) the following day.

3. Patients and Methods

In this randomized, blinded trial 63 patients were enrolled. Following approval from the institutional review board all patients provided written informed consent. Potential subjects were identified during the clinic visit in the Urology Department and pre-admission testing appointments. Study inclusion criteria consisted of age greater than 65, female subjects scheduled for brief urologic surgery (Cyctoscopy, Ureteral stent, Laser lithotripsy, Ureteroscopy, Vaginal sling, Bladder injury repair, Rectocele repair and Stone extraction), ability to read, write and speak English language. Exclusion criteria consisted of preexisting neurological impairment in thinking process, renal insufficiency or failure, and lack of command of English language. This study is a double blinded randomized controled trial. Patients were randomized to receive either a desflurane or sevoflurane-based anesthetic. The selection of the anesthetic gas (sevoflurane or desflurane) was determined by computer generated randomization. Only the anesthesiology provider had knowledge of which gas had been administered to the subject. The anesthesiology provider was not involved in the data collection. All the investigators and co-investigators who collected the research data were blinded to the gas selection. On the morning of the surgery the study investigator asked the subjects to perform a baseline cognitive task tests to determine the baseline thinking process. A detailed description of the cognitive task is as following:

a) Mini-Mental Status Exam (MMSE): (10-15 minutes). This is a 30-item measure of global cognition (Folstein, Folstein and McHugh, 1975) that tests orientation to time and place, object naming, repetition, attention, recall, and following complex commands.

b) Trail Making Test Part A and Part B: Part A (3 minutes) of this measure (Army Individual Test Battery, 1944; Reitan and Wolfson, 1985) is a test of visual attention where the subjects must draw lines on a page connecting 25 consecutive numbers as quickly as possible. Part B (5 minutes) requires the subject to alternately sequence numbers and letters randomly distributed on a page into their ascending and alphabetical order as quickly as possible.

c) Digit Symbol Coding: (2 minutes). This subtest of the WAIS-III (Wechsler, 1997) consists of nine digit-symbol pairs followed by a list of digits. Under each digit the subject must write down the corresponding symbol as quickly as possible.

d) Hopkins Verbal Learning Test-Revised (HVLT-R): (8 minutes) Memory for verbal information will be assessed with this list learning task assessing immediate and delayed recall.

e) Stroop Color and Word Test: (5 minutes). This test (Stroop, 1935; Golden, 2002) measures cognitive control by asking subjects to suppress a habitual response in favor of an alternate response. Participants are shown a word and asked to name the color in which the word is written.

Total time expected for cognitive task tests is 28-33 min. After testing, the subjects underwent their planned procedure. The selection of the anesthetic gas was determined by a computer generated randomization list. The investigators and the subjects were blinded to the anesthetic gas given. At the conclusion of the surgery, the anesthetic gas was discontinued and the time to eye opening after cessation of the gas was documented. At 30 minutes and 2 hours after discontinuation of the anesthetic gas, the subjects were asked to repeat the same sets of cognitive task tests. On post-operative day 1 the co-investigator had telephone conversation with the subjects who were discharged home after surgery. Modified Telephone Interview for Cognitive Status (TICS-M) and Memory Aging Telephone Screen (MATS) were used to collect data (10 minutes). TICS-M is a 13-item telephone interview (Welsh, Breitner, and Magruder-Habib, 1993) for late-life cognitive assessment that includes tests of orientation, attention, working memory, praxis, sentence repetition, naming to verbal description, recent memory, word opposites, and an additional immediate and delayed recall of a 10-word list. MATS consists of a subjective cognitive complaints questionnaire on subjects' perceived cognitive decline and 10 cognitive items assessing verbal memory (Rabin et al., 2007). The subjects’ participation concluded after follow-up telephone conversation. On arrival in the OR, a peripheral IV was placed and patients received metoclopramide 10 mg, fentanyl 50 ug and propofol 2 mg/kg. Patients were randomly assigned to receive either desflurane or sevoflurane, breathing spontaneously via laryngeal mask airway, with end-tidal concentration recorded every 5 minutes. Concentration was initially set to 6 volume% for desflurane and 2 volume% for sevoflurane in oxygen. Before the conclusion of surgery, patients received 4 mg of ondansetron, IV and 30 mg of ketorolac, IV. At the conclusion of the surgery, identified as completion of last skin suture, volatile anesthetic discontinuation occurred and a blinded observer entered the operating room to record time to eye opening when prompted by the anesthesia practitioner every 10 seconds. Removal of the LMA preceded patient transport to the PACU while monitoring by the same blinded observer continued. Cognitive testing at the specified time intervals occurred in PACU. Testing and data were subsequently collected before hospital discharge and in the surgeon’s office the following day. In the PACU patients received 12.5 to 25 ug fentanyl, as necessary for breakthrough pain.

3.1. Statistical Methods

This study was powered off of Mahmoud et al. with a sample size of (n = 60) and with the primary endpoint being time to opening of eyes following discontinuation of volatile anesthetic (1). The data was analyzed using Student’s t-test for patient characteristics and Mann-Whitney for nonparametric data. This is similar to the anesthetic technique and data analysis in Mahmoud et al. (1) A sample size of 30 subjects in each treatment group provided at least 80% power to detect a difference of 4 minutes in time to eye opening, assuming a standard deviation of 5.0 minutes (α = 0.05, 2-tailed). The detectable difference in time to eye opening of 4 minutes is taken from the Mahmoud et al. (1) where 16-75 year old females scheduled for minor day-case gynecological procedure (2.8 minutes for desflurane, 7.0 minutes for isoflurane). The standard deviation estimate of 5 minutes is a conservative estimation, which is based on the quoted observed range of time to eye opening (1 to 12 minutes) in Mahmoud et al. Additionally, this conservative estimation of the standard deviation was selected to reflect the older population in this study as that compared to Mahmoud et al. (1).

3.2. Statistical Analysis

Data entry and analysis was performed with SPSS (version: 20.0, SPSS Inc, Chicago, USA). Demographic and patient characteristics were obtained for all enrolled subjects. Mean ± SD were obtained for age, time to open eyes, and time to discharge from PACU. Number of observations and percentages were obtained for ethnicity, marital status, education level and medical history (physical disability, cognitive disability, visual difficulties, assistance with Activities of Daily Living (ADL), neurological disorders, traumatic brain injury, psychiatric disorders, and depression/anxiety). Median and range were obtained for time to eye opening, time to discharge from PACU and scores from neurocognitive test battery. Comparison between the study groups for anesthesia recovery time and scores of 24-hours follow-up tests were done by performing Mann Whitney U Test. The differences in scores of pre and post-surgery neurocognitive tests were compared by performing Wilcoxon Signed Rank test. Statistical significance was set at 0.05 and test statistics, effect size and P values were reported.

4. Results

A total of 63 subjects were enrolled and randomized into two groups, 31 subjects in desflurane Group and 32 in sevoflurane Group. Six patients were not included due to cancelation or postponement of surgery or changes in the anesthesia care plan. The remaining 57 subjects were enrolled and 51 subjects agreed to complete a study questionnaire (background information and impairments) and participate in neurocognitive testing. A total of 15 subjects managed to complete at least one test from the test battery at either pre-surgery, 30-minutes post-surgery, 2-hours post-surgery or 24 hours follow-up tests. Only one subject was able to complete all the tests in the battery at all the designated times (Figure 1) Demographic and patient characteristics are presented in Table 1. Anesthesia recovery time was recorded for all enrolled subjects, mean ± SD of time to eye opening and time to discharge from PACU (Aldrete > 9) are presented in Table 2. Comparisons of anesthesia recovery time and 24-hours follow-up neurocognitive test scores were presented in Table 3. Time to eye opening and time to discharge from PACU were slightly faster in subjects who were randomized into desflurane group. These differences did not reach statistical significance. Scores of neurocognitive tests performed at pre and post-surgery are presented in Table 4 (desflurane group) and Table 5 (sevoflurane group). Subjects in desflurane group performed slightly better than the subjects in sevoflurane group in most of the neurocognitive tests. Comparison of these scores showed no statistically significant differences between the study groups. A statistically significant difference was seen in comparison of pre-surgery and post-surgery scores of Trail Making Test Part B. This difference was only seen in the desflurane group. However, the scores for this test and all the other tests were within average score range for elderly females without cognitive impairment. No other statistically significant differences were seen between pre and post-surgery scores for both study groups.

Table 1. Demographic and Patient Characteristics of Study Population (n = 63) a
Desflurane PatientsSevoflurane Patients
Age, y68.2 ± 6.4367.1 ± 6.11
Ethnicity
Caucasian13 (14.9)12 (37.5)
Black14 (45.2)15 (46.9)
Hispanic4 (12.9)5 (15.6)
Marital Status
Married13 (48.1)3 (12.0)
Single4 (14.8)15 (60.0)
Widow5 (18.5)6 (24.0)
Divorced4 (15.4)1 (4.0)
Education level
Grade School3 (11.5)3 (12.0)
High School16 (61.5)15 (60.0)
College7 (26.9)6 (24.0)
Post-graduate01 (4.0)
Physical disability03 (12.0)
Cognitive Disability1 (3.8)0
Visual Difficulties11 (42.3)12 (48.0)
Assistance with ADL02 (8.0)
Neurological Disorder1 (3.8)2 (8.0)
Traumatic brain injury01 (4.0)
Psychiatric Disorder2 (7.7)1 (4.0)
Depression/Anxiety3 (11.5)2 (14.3)

aData are presented as No. (%) or Mean ± SD.

Table 2. Anesthesia Recovery Time of the Study Population (n = 57) a
Desflurane PatientsSevoflurane PatientsP Value
Time to eye opening, seconds391.2 ± 250.04446.5 ± 228.190.194
Time to discharge from PACU, min95.0 ± 34.24104.9 ± 49.820.558

aData are presented as Mean ± SD.

Table 3. Comparison Between Study Groups
Desflurane PatientsSevoflurane PatientsU ValueZ Valuer ValueP Value
No. (%)Median (Range)No. (%)Median (Range)
Time to eye opening, sec31 (100)340 (60-1440)26 (100)395 (60-1080)322-1.300.20.194
Time to discharge from PACU, min31 (100)85 (40-180)26 (100)109.5 (33-247)366.5-0.590.10.558
TICS-M Total Score, ( /39)8 (25.8)25 (15-33)6 (23.1)20 (10-30)15-1.160.30.244
MATS Total Score of memory complaints, ( /12)8 (25.8)3.5 (0-7)6 (23.1)6 (0-8)15-1.170.30.241
Table 4. Comparison of Pre and Post-Surgery Test Scores in Desflurane Group (n = 31) a
Pre Surgery30 min Post Surgery2 hours Post-SurgeryZ Valuer ValueP Value
No. (%)Median (Range)No. (%)Median (Range)NO. (%)Median (Range)
HVLT
(Delayed recall score/ highest recall score, %)8 (25.8)85 (57-160)2 (6.5)82 (50-113)5 (16.1)63 (0-70)-1.070.30.285
MMSE
Total score, (/30)9 (29.0)29 (23-30)2 (6.5)29 (27-30)6 (19.4)30 (20-30)0--
Trail making part A
Total time, sec9 (29.0)40 (24-65)2 (6.5)39 (38-40)6 (19.4)40 (30-60)-0.670.20.500
Trail making part B
Total time, sec8 (25.8)74 (42-155)2 (6.5)88 (66-110)6 (19.4)103 (60-175)-2.020.60.043
Stroop color and word Test
Interference ratio (color word score/ color score) in 45 seconds8 (25.8)0.5 (0.51-0.80)2 (6.5)0.4 (0.36-0.43)5 (16.1)0.4 (0.32-0.80)-0.730.20.465
Digit symbol coding
Score in 90 seconds4 (12.9)23 (19-32)2 (6.5)33 (18-48)5 (16.1)35 (21-37)-1.340.40.180

aAbbreviations: HVLT, Hopkins Verbal Learning Test; mini-mental status exam.

Table 5. Comparison of Pre and Post-Surgery Test Scores in Sevoflurane Group (n = 26) a
Pre Surgery30 mins Post Surgery2 hours Post-SurgeryZ Valuer ValueP Value
No. (%)Median (Range)No. (%)Median (Range)NO. (%)Median (Range)
HVLT
(Delayed recall score/ highest recall score, %)4 (15.4)38 (0-40)0-2 (7.7)25 (0-50)-0.450.20.655
MMSE
Total score, (/30)6 (23.1)28 (20-30)0-3 (11.5)29 (21-30)-0.450.20.655
Trail making part A
Total time, sec6 (23.1)54 (27-113)0-2 (7.7)47 (42-52)-1.340.50.180
Trail making part B
Total time, sec6 (23.1)112 (38-188)0-2 (7.7)96 (90-101)-0.450.20.665
Stroop color and word test
Interference ratio (Color Word Score/ Color Score) in 45 seconds5 (19.2)0.4 (0.36-0.59)0-2 (7.7)0.3 (0.04-0.45)-1.340.50.180
Digit symbol coding
Score in 90 seconds6 (23.1)27 (12-40)0-2 (7.7)35 (34-36)-1.340.50.180

aAbbreviations: HVLT, Hopkins Verbal Learning Test; mini-mental status exam.

5. Discussion

This study questioned the difference between volatile anesthetic agent’s effects on patients completing a battery of neurocognitive tests attempting to answer the question if one agent has a more profound effect verse the other. These tests were completed both immediately following surgery and on postoperative day 1. Our results did not reach statistical difference. This included the testing done the following day, TICS-M and MATS. While these cognitive tests have been proven to be reliable and valid screening tools for dementia, question still remain regarding use in anesthetized patients. Of note, in the desflurane group, the trail making part B (TMP-B) test result in seconds did prove to be longer versus pre-surgery testing. TMP-B is a well validated test to differentiate between normal and pathological aging (5). TMP-B requires cognitive flexibility, working memory, set-shifting abilities, the ability to maintain two response sets as well as inhibitory functions (5). This specific test focuses on not just cognitive processing speed but also considers attention switching difficulties (6). No difference was seen in the pre and post-operative values in the sevoflurane group. This is a very common tool used to assess cognitive fitness to drive in people with possible dementia (7) and as a critical piece in an assessment of executive function in neurodegenerative disorders (5). More study is needed to assess if desflurane has a greater impact on the neurocognitive test TMP-B than sevoflurane. The significance of this finding, effect on driving or executive function, remains to be answered. This study has several limitations which centers on the case type and setting in which the surgery took place. Short procedure or same day surgery units are inherently dependent on both rapid room turn over and short post anesthesia care unity time stays. This precluded neurocognitive testing completion. Because of this, while the study design was novel and provides what could be a good framework for future studies, the final results lacked power to show the statistical significance proving or disproving our hypothesis. However; several key inferences can be made. There was no statistical difference in time from vaporizer shut off to eye opening between the two groups. This is contradictory to previously reported findings (1, 8). The data was trending, but no real definitive conclusion can be made due to lack of statistical significance. Our findings are consistent with previously published reports which show no difference in time to discharge from the post-operative care unit (3, 8-11). Postoperative cognitive dysfunction (POCD) will continue to become more of a concern as the average lifespan continues to lengthen. POCD, while classically associated with cardiac surgery, is present in 30-40% of all adult patients regardless of age (12, 13). In patients over 60 years old it can persist for up to 3 months (14). This was not shown to be associated with length or procedure or anesthetic type (15-17). Instead, inflammation caused by the stress of surgery was implicated as the cause of cognitive decline (18, 19). Volatile agents themselves have been implicated as causative factors in cognitive decline but no difference in incidence was seen between sevoflurane and desflurane (20-23). Our study shows no statistically significant cognitive decline in any testing group except for those in the trail making part B desflurane group. This conclusion is limited by the inherent limitations of the study, but does reinforce the theory that the systemic inflammatory response from the surgery causes POCD (18, 19). Our patient population underwent same day urology procedures which cause minimal systemic inflammation and therefore would cause minimal POCD regardless of volatile anesthetic choice. Further study is needed to define impact.

Acknowledgements

Footnote

References

  • 1.

    Mahmoud NA, Rose DJ, Laurence AS. Desflurane or sevoflurane for gynaecological day-case anaesthesia with spontaneous respiration? Anaesthesia. 2001; 56(2) : 171 -4 [PubMed]

  • 2.

    Bilotta F, Doronzio A, Cuzzone V, Caramia R, Rosa G, Pinocchio Study Group . Early postoperative cognitive recovery and gas exchange patterns after balanced anesthesia with sevoflurane or desflurane in overweight and obese patients undergoing craniotomy: a prospective randomized trial. J Neurosurg Anesthesiol. 2009; 21(3) : 207 -13 [DOI][PubMed]

  • 3.

    Strum EM, Szenohradszki J, Kaufman WA, Anthone GJ, Manz IL, Lumb PD. Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study. Anesth Analg. 2004; 99(6) : 1848 -53 [DOI][PubMed]

  • 4.

    Sinclair DR, Chung F, Smiley A. General anesthesia does not impair simulator driving skills in volunteers in the immediate recovery period - a pilot study. Can J Anaesth. 2003; 50(3) : 238 -45 [DOI][PubMed]

  • 5.

    Muller LD, Guhn A, Zeller JB, Biehl SC, Dresler T, Hahn T, et al. Neural correlates of a standardized version of the trail making test in young and elderly adults: a functional near-infrared spectroscopy study. Neuropsychologia. 2014; 56 : 271 -9 [DOI][PubMed]

  • 6.

    Salthouse TA, Toth J, Daniels K, Parks C, Pak R, Wolbrette M, et al. Effects of aging on efficiency of task switching in a variant of the trail making test. Neuropsychology. 2000; 14(1) : 102 -11 [PubMed]

  • 7.

    Staplin L, Gish KW, Sifrit KJ. Using cognitive status to predict crash risk: blazing new trails? J Safety Res. 2014; 48 : 19 -25 [DOI][PubMed]

  • 8.

    Nathanson MH, Fredman B, Smith I, White PF. Sevoflurane versus desflurane for outpatient anesthesia: a comparison of maintenance and recovery profiles. Anesth Analg. 1995; 81(6) : 1186 -90 [PubMed]

  • 9.

    Song D, Joshi GP, White PF. Fast-track eligibility after ambulatory anesthesia: a comparison of desflurane, sevoflurane, and propofol. Anesth Analg. 1998; 86(2) : 267 -73 [PubMed]

  • 10.

    Heavner JE, Kaye AD, Lin BK, King T. Recovery of elderly patients from two or more hours of desflurane or sevoflurane anaesthesia. Br J Anaesth. 2003; 91(4) : 502 -6 [PubMed]

  • 11.

    Chen X, Zhao M, White PF, Li S, Tang J, Wender RH, et al. The recovery of cognitive function after general anesthesia in elderly patients: a comparison of desflurane and sevoflurane. Anesth Analg. 2001; 93(6) : 1489 -94 [PubMed]

  • 12.

    Gao L, Taha R, Gauvin D, Othmen LB, Wang Y, Blaise G. Postoperative cognitive dysfunction after cardiac surgery. Chest. 2005; 128(5) : 3664 -70 [DOI][PubMed]

  • 13.

    Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008; 108(1) : 18 -30 [DOI][PubMed]

  • 14.

    Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 1998; 351(9106) : 857 -61 [PubMed]

  • 15.

    Bryson GL, Wyand A. Evidence-based clinical update: general anesthesia and the risk of delirium and postoperative cognitive dysfunction. Can J Anaesth. 2006; 53(7) : 669 -77 [DOI][PubMed]

  • 16.

    Newman S, Stygall J, Hirani S, Shaefi S, Maze M. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology. 2007; 106(3) : 572 -90 [PubMed]

  • 17.

    Hudson AE, Hemmings HJ. Are anaesthetics toxic to the brain? Br J Anaesth. 2011; 107(1) : 30 -7 [DOI][PubMed]

  • 18.

    Lin D, Zuo Z. Isoflurane induces hippocampal cell injury and cognitive impairments in adult rats. Neuropharmacology. 2011; 61(8) : 1354 -9 [DOI][PubMed]

  • 19.

    Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol. 2010; 68(3) : 360 -8 [DOI][PubMed]

  • 20.

    Fodale V, Santamaria LB, Schifilliti D, Mandal PK. Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease. Anaesthesia. 2010; 65(4) : 388 -95 [DOI][PubMed]

  • 21.

    Ancelin ML, de Roquefeuil G, Scali J, Bonnel F, Adam JF, Cheminal JC, et al. Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents. J Alzheimers Dis. 2010; 22 Suppl 3 : 105 -13 [DOI][PubMed]

  • 22.

    Kadoi Y, Goto F. Sevoflurane anesthesia did not affect postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery. J Anesth. 2007; 21(3) : 330 -5 [DOI][PubMed]

  • 23.

    Rortgen D, Kloos J, Fries M, Grottke O, Rex S, Rossaint R, et al. Comparison of early cognitive function and recovery after desflurane or sevoflurane anaesthesia in the elderly: a double-blinded randomized controlled trial. Br J Anaesth. 2010; 104(2) : 167 -74 [DOI][PubMed]

  • COMMENTS

    LEAVE A COMMENT HERE: